Review Article
Management of Non-Vitamin K Antagonist Oral Anticoagulants in the Perioperative Setting
Table 8
Essential prerequisites allowing perioperative decisions.
| Molecule | Type | Dose | Indication |
| Patient | Thromboembolic risk—bleeding risk | Renal function (CrCl—Cockroft and Gault formula) | Hepatic function | Concomitant drugs | Approved NOAC’s indication |
| Procedure | Type and technique | Bleeding risk | Date of its achievement (Day 0) |
| Anesthesia | General and/or regional (neuroaxial or peripheral nerve blocks) |
|
|